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Short Communication 
The kinetics of chondroitin 4-sulfate 
release from stimulated platelets and 
its relation to thromboxane A2 formation 
and granule secretion 
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I. In platelet rich plasma (PRP), chondroitin 4-sulfatc relcase from platelets occurred 
after stimulation with ADP (5 ,uM), collagen (5-1 O ,ug/ml}, or adrenalinc (lO 11M). Rclease started 
within 60s and maximum release (0.7-2.0 mg/1} was reached within 180 s. TXA2 formation and 
densc granule rclcase reached a maximum within 90s after stimulation. 
2. Using washed platelets {1.5 x I 08 cells/ml), the platelet responscs wcrc faster. Release 
of chondroitin 4-sulfate and TXA2 startcd within 20-30 s aftcr thrombin addition (100 mU!ml). 
Maximum rclcase was reached within 60s in both cases. Dense granule relcasc started in the first 5 
s of stimulation (34.6 ~ 12.4%) rcaching maximurn sccretion (74.4 ~ 8.7%) within 60s. 
3. Our rcsults dernonstrate that maximal chondroitin 4-sulfate rclcasc occurs after the 
dcnse granule relcase rcaction in both PRP and washed platelets. This observation suggests that 
chondroi tin 4-sulfatc is unlikcly to be storcd in thc dcnse granules but may bc storcd in thc a-
granules. 
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Introduction 
Platelets contain Jarge amounts of proteoglycans in their membranes 
and in their storage granules. In the Jatter case, lhe proteoglycans are present in 
the same subcellular fraction as platelet factor-4 (Barber et ai., 1972). Chon-
droitin 4-sulfate, which accounts for more than 90% of the platelet proteoglycan 
content (Barber et ai., 1972; Nader, 1991), is thought to be the carrier molecule 
for platelet factor-4 (Barber et ai., 1972; Luscombe et ai., 1981, Huang et ai., 
1982) and has been irnplicated in cell-cell interactions (Sampaio and Dietrich, 
1981). In addition, a high molecular weight chondroitin sulfate (Mr 240,000) is 
known to be released from platelets during aggregation induced by severa] 
agonists including ADP, adrenaline, noradrenaline, serotonin, collagcn and throm-
bin (Nader, 1991). 
We describe the time course of chondroitin 4-su lfate release during 
platelet activation anel aggregation incluced by various stimuli. We have also 
studied the correlation bctween this release and the biosynthcsis of thromboxane 
A2 (TXA2) and the liberation of dense granule contents. 
Material and Methods 
Platelet preparation and stimulation 
Human blood was anticoagulated with 3.8% sodium citrate (1:10) anel 
platelet rich plasma (PRP) was prepared by differential centrifugation. Washed 
platelets were prepared as described by Radomski and Mancada (1983). Platelet 
aggregation was monitored using a Born-type aggregometer. 
Release reaction 
Platelets were labelled in PRP by incubation with 0.5 rnM [1 4C]5-HT 
(50 Ci/mrnol) for 30 min at 37°C. Prior to stimulation, lhe platelcts were incu-
bated with imipramine (1 mM) for at Jeast 15 min in arder to minimize the 
reuptake of released 5-HT. After addition of the agonist, aggregation was allowed 
to proceeel for 5 min anel the reaction was terminateel by aeleling 100 ,ui of 100 mM 
EDT A. The aggregatecl platelet suspensions were then centrifugcel at 12,000 g fo r 
2 min. The extent of granule (14C]5-HT release was eletermineel by quantifying the 
raelioactivity in 100 ,ui of thc resulting supernatant. The results are reported as 
percent of lhe total [14C]5-HT content in 100 ,ui of platelet suspension (Holmsen 
and Weiss, 1979). 
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TXB2 determination 
. TXA2 formation was quantifieel by raelioimmunoassay of its stablc 
elegradatton produc_t TXB2 (Salmo.n, 1978). Following aggregation, lhe platelet 
samplcs wer~ ccntn.fugcd as descnbeel above anel the supernatants removeel anel 
stored a_t -20 C unttl ass;tyed. Thc results are reported as no TXB,/ml late) 
suspens10n. 0 - P et 
Quawification o[ clwndroitin 4-sulfate 
Th~ amount _o f chondroitin 4-sul fale releascd was quantified in both lhe 
s~luble fract10n and tn the platclct pcllct obtaineel aftcr thc centrifugation of 
stunulated platelets as describccl abovc. The proccdure for the se .1 1· • c1 ·d ·r· . · . . p, ra ton an 
1 et~~· tc,tlton of the ~lycosammoglycans obtainecl from the platelets after prote-
olysts has bccn dcscnbcd clscwhcrc (Nader, 199l). 
Results and Discussion 
. . In P~P, chonelroi tin 4-sulfatc rclease from platelcts occurreel after 
slt~udatton \~tth ~DP (5 pM), colla_ge~l (5-1 O pg/ml), or aelrenaline (10 pM). 
\~ttl: these sllm_uh, rclease sta:tecl wt~htn 60s anel was maximal (0.7-2.0 mg/1) 
wtt~ll.n 180 s. S11nultaneous wtth the mcrcase in the supernalant levei of chon-
drottm 4-sulfale, lhere was a elecrcasc in the levei of this proteoglycan in lhe 
~latelet pellet. Th~ rclease of chonelroilin 4-sulfate occurred after TXB, forma-
tton ~nel Ih~ secretton of lhe ~ense gr<~m~ le contents, as shown by the [•4-C]5-HT 
release whtch reached a max11num Wtlhtn 90s after stimulation (Fio c I) N I el . . 4 our . O 
c lOn roJtm -sulfatc, TXB2 formation or clense granule release was observed 
when a low dose of ADP (1.5 pM), which was unable to induce the second phase 
of platelet aggregation, was used. 
With washeel platelets (1.5 x J QH cells/ml), lhe release of chonclroitin 4-
sulfate ~~d TXB2 was_faster anel startecl within 20-30 s after thrombin (100 mUI 
ml) addttton. Thc maxmlllm arnount rcleasecl in both cases was reacheel within 60 
s .. The el_cnse granule rei case in the presence o f thrombin slarted within 5 s o f 
SIJ~nulattOn (34.6:!: 12.4%) anel reachcel a maximum of 74.4:!: 8.7% within 60s 
(Ftgure 1). In lhe first 15 s after stirnulation therc was no chondroitin 4-sulfate 
re_lease from ~vashcd pl~telets. Hagcn (1972) has previously shown that platelets 
511~1ulateel wtth thrombtn ( 4 U/ml) and latcx released both adeninc nucleoticles 
whtch ~re also stored in platclet clense granules, anel glycosaminooJycans with th; 
same ltme course. This cliscrepancy most likely reflects the fact ~hat Haoen uscd 
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40-fold more thrombin than used here. Under such condilions, lhe granule release 
reaclion and other biochemical evcnts are very rapid and it becomes impossible to 
dissociate them in a time-course cxperirnent. 
It is known that when platelets are stimulated, lhe dense granule con-
tents are relcased first, followed by the a-granule release (Rendu and Dupuy, 
1991). Our results demonslrate that maximal chondroitin 4-sulfate release occurs 
after lhe dense granule relcase reaction in both PRP and washed platelets. This 
observation suggests thal chondroitin 4-sulfate is unlikely to be stored in the 
dense granules but may be stored in the a-granules. 
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